Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 10/20 | 0.64 |
| ▸ | XDH | P47989 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | QPCT | Q16769 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32680056 | 0.83 | MPO (0.92) | MPOXDHALDH1A1HPGDHSD17B10 | |
| SCHEMBL10288922 | 0.83 | MPO (0.92) | MPOXDHALDH1A1HPGDHSD17B10 | |
| SCHEMBL25335252 | 0.76 | MPO (0.63) | MPOALDH1A1HPGDKMT2AHSD17B10 | |
| SCHEMBL25333362 | 0.76 | ALDH1A1 (0.64) | MPOALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL25333651 | 0.76 | MPO (0.82) | MPOXDHALDH1A1HPGDKMT2A | |
| SCHEMBL25810869 | 0.74 | MPO (0.55) | MPOXDHALDH1A1HPGDKMT2A | |
| SCHEMBL2731546 | 0.71 | MPO (1.00) | MPOXDHALDH1A1HAVCR2 | |
| SCHEMBL17501680 | 0.70 | HSD17B10 (0.49) | MPOALDH1A1HPGDKMT2AHSD17B10 | |
| SCHEMBL5112012 | 0.69 | ALDH1A1 (0.73) | MPOALDH1A1HPGDKMT2AHSD17B10 | |
| SCHEMBL8987938 | 0.69 | ALDH1A1 (0.73) | MPOXDHALDH1A1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023133240-A1 | COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT | REVELA, INC. (US) | 2023-07-13 | — | — | WO | disclosed |